免疫原性
布鲁氏菌
病毒学
布鲁氏菌病
生物
毒力
减毒疫苗
抗原
免疫系统
dna疫苗
微生物学
免疫
免疫
免疫学
遗传学
基因
作者
Leonardo A. Gómez,Francisco I. Alvarez,Daniel Betancur,Ángel Oñate
出处
期刊:Vaccine
[Elsevier BV]
日期:2018-04-30
卷期号:36 (21): 2928-2936
被引量:14
标识
DOI:10.1016/j.vaccine.2018.04.014
摘要
Brucella abortus is the etiological agent of brucellosis, a zoonotic disease affecting cattle and humans. This disease has been partially controlled in cattle by immunization with live attenuated B. abortus S19 and RB51 strains. However, use of these vaccine strains has been associated with safety issues in animals and humans. New vaccines have since emerged in the prevention of brucellosis, particularly DNA vaccines, which have shown effectiveness and a good safety profile. Their protection efficacy in mice is associated with the induction of Th1 type and cytotoxic T cell mediated immune response against structural antigens and virulence factors expressed during B. abortus infection. Some antigenic candidate for vaccine design against brucellosis (mainly DNA vaccines) have been obtained from genomic island 3 (GI-3) of B. abortus, which encodes several open reading frames (ORFs) involved in the intracellular survival and virulence of this pathogen. The immunogenicity and protection conferred by these DNA vaccines in a murine model is reviewed in this article, suggesting that some of them could be safe and effective vaccine candidates against to prevent B. abortus infection.
科研通智能强力驱动
Strongly Powered by AbleSci AI